Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,141 | 28,828 | 12,667 | 34,185 | 49,041 |
| Marketable Securities | 313,056 | 317,879 | 124,385 | 109,441 | 109,046 |
| Receivables | 37,494 | 646 | 2,013 | 1,629 | 1,869 |
| TOTAL | $373,155 | $353,096 | $143,921 | $149,217 | $164,621 |
| Non-Current Assets | |||||
| PPE Net | 1,079 | 1,090 | 1,304 | 1,721 | 1,946 |
| Intangibles | 1,314 | 1,350 | 1,387 | 1,423 | 1,459 |
| Other Non-Current Assets | 5,678 | 3,822 | 4,954 | 5,893 | 7,031 |
| TOTAL | $8,071 | $6,262 | $7,645 | $9,037 | $10,436 |
| Total Assets | $381,226 | $359,358 | $151,566 | $158,254 | $175,057 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,939 | 1,368 | 1,301 | 646 | 227 |
| Accrued Expenses | 12,353 | 11,923 | 14,197 | 12,408 | 11,503 |
| TOTAL | $39,861 | $34,023 | $46,615 | $41,029 | $39,223 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 24,073 | 17,876 | 26,877 | 22,379 | 22,050 |
| Other Non-Current Liabilities | 8,680 | 4,412 | 4,353 | 4,299 | 5,683 |
| TOTAL | $39,297 | $5,391 | $5,943 | $9,836 | $15,924 |
| Total Liabilities | $79,158 | $39,414 | $52,558 | $50,865 | $55,147 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 217,899 | 217,703 | 170,187 | 169,435 | 164,913 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -750,863 | -730,197 | -711,949 | -682,437 | -668,208 |
| Other shareholders' equity | -196 | 102 | 111 | 104 | 33 |
| TOTAL | $302,068 | $319,944 | $99,008 | $107,389 | $119,910 |
| Total Liabilities And Equity | $381,226 | $359,358 | $151,566 | $158,254 | $175,057 |